-
Today, advanced treatment with highly active antiretroviral therapy (HAART) has pushed back the development of AIDS in many HIV-positive patients. Consequently, more people are living longer with HIV infection, increasing the likelihood that patients will present to the emergency department (ED) at some time during the course of their illness.
-
It has been a tough few months for marketers of vitamins and herbal products. Calcium plus vitamin D, saw palmetto, and glucosamine/chondroitin have all been the subject of studies that have questioned their efficacy.
-
Noninferiority trials are usually designed to show that product B, which entered the therapeutic arena after product A, does not fall below a prespecified margin of efficacy compared to product A, ...
-
The availability of a growing number of therapeutic options for acute stroke patients makes rapid and reliable diagnosis of stroke at the bedside more important than ever.
-
There is a wide variation in the rate of coronary heart disease (CHD) in diabetes, depending on the population and existing risk factors.
-
-
A picture of a 12-lead ECG was obtained from a healthy 32 year old man who had some atypical chest pain. Although there are no ECG findings suggestive of acute ischemia, doctors disagree with the computer interpretation ...
-
The fda has approved a new drug with a unique mechanism of action for the treatment of chronic angina. Ranolazine reduces the frequency of chest pains by reducing the demand for oxygen but does not have significant effect on heart rate or blood pressure.
-
Long-term use of warfarin is associated with an increase in osteoporotic fractures.
-
Future research will demonstrate whether these tests can also document and monitor the benefit of specific therapeutic interventions.